Review of fetal and neonatal immune cytopenias

Clinical Advances in Hematology and Oncology

Volumn 13, Issue 1, 2015, Pages 35-43

  Lewin, Sharon ^a,b   Bussel, James B ^c,d  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b Division of Newborn Medicine   (United States)

^c Department of Obstetrics and Gynecology Department of Medicine ^*  (United States)

^d Division of Pediatric Hematology and Oncology   (United States)

Author keywords

Fetoplacental unit; Immune mediated; Neonatal; Thrombocytopenia; Treatment with intravenous immune globulin (IVIG)

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; PREDNISONE;

ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BREAST FEEDING; BURST FORMING UNIT; CYTOKINE PRODUCTION; DOPPLER FLOWMETRY; ERYTHROBLAST; HEMOCHROMATOSIS; HUMAN; LYMPHOPOIESIS; MEGAKARYOCYTE; MIDDLE CEREBRAL ARTERY; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEUTROPENIA; NEUTROPHIL CHEMOTAXIS; PLACENTAL TRANSFER; PREECLAMPSIA; SIGNAL TRANSDUCTION; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; COMPLICATION; FEMALE; FETAL DISEASES; FETOMATERNAL TRANSFUSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOLOGY; NEWBORN; PREGNANCY; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

BREAST FEEDING; FEMALE; FETAL DISEASES; HEMOCHROMATOSIS; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; NEUTROPENIA; PRE-ECLAMPSIA; PREGNANCY; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84921634599     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Palis J, Segel GB. Hematology of the fetus and newborn. In: Lichtman MA, Kipps TJ, Seligsohn U, Kaushansky S, Prchal J T. Williams Hematology. 8th ed. New York, NY: McGraw-Hill; 2010:87-104.
2. Liu ZJ, Sola-Visner M. Neonatal and adult megakaryopoeisis. Curr Opin Hema-tol. 2011;18(5):330-337.
3. Lopriore E, Rath ME, Liley H, Smits-Wintjens VE. Improving the management and outcome in haemolytic disease of the foetus and newborn. Blood Transfus. 2013;11(4):484-486.
4. Stockman JA III, de Alarcon PA. Overview of the state of the art of Rh disease: history, current clinical management, and recent progress. J Pediatr Hematol Oncol. 2001;23(6):385-393.
5. Murray NA, Roberts IA. Haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2007;92(2):F83-F88.
6. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobu- lin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed. 2003;88(1):F6-F10.
7. U.S. Preventive Services Task Force. Rh (D) Incompatibility, Screening: Final Recommen dation Statement. Rockville, MD: Agency for Healthcare Research and Quality; 2004.
8. American College of Obstetrics and Gynecology. ACOG practice bulletin. Prevention of Rh D alloimmunization. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 1999;66(1):63-70.
9. Moise KJ Jr. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol. 2008;112(1):164-176.
10. Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmuniza-tion in pregnancy: a systematic review. Obstet Gynecol. 2012;120(5):1132-1139.
11. Chitkara U, Bussel J, Alvarez M, Lynch L, Meisel RL, Berkowitz RL. High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis? Obstet Gynecol. 1990;76(4):703-708.
12. Ruma MS, Moise KJ Jr, Kim E, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmuniza-tion. Am J Obstet Gynecol. 2007;196(2):138e1-138e6.
13. Millard DD, Gidding SS, Socol ML, MacGregor SN, Dooley SL, Ney A, Stockman JA. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemoly-sis and erythropoeisis in severe fetal isoimmunization. J Pediatr. 1990;117(3):447-454.
14. Scaravadou A, Inalis S, Peterson P, Dunne J, Chervenak F, Bussel J. Suppression of erythropoeisis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr. 1993;123(2):279-284.
15. Ohls RK, Wirkus PE, Christensen RD. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease. Pediatrics. 1992;90(5):678-680.
16. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer. 2005;45(2):176-183.
17. Bussel JB, Berkowitz RL, Hung C, et al. Intracranial hemorrhage in alloim-mune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol. 2010;203(2):135e1-14.
18. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med. 1997;337(1):22-26.
19. Lynch L, Bussel JB, McFarland JG, Chitkara U, Berkowitz RL. Antenatal treatment of alloimmune thrombocytopenia. Obstet Gynecol. 1992;80(1):67-71.
20. Berkowitz RL, Kolb EA, McFarland JG, et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol. 2006;107(1):91-96.
21. Vinograd CA, Bussel JB. Antenatal treatment of fetal alloimmune thrombocy-topenia: a current perspective. Haematologica. 2010;95(11):1807-1811.
22. Kaplan C, Dafos F, Forestier F, et al. Fetal platelet counts in thrombocytopenic pregnancy. Lancet. 1990;336(8721):979-982.
23. Bussel JB, Druzin ML, Cines DB, Samuels P. Trombocytopenia in pregnancy. Lancet. 1991;337(8735):251.
24. Burrows R F, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329(20):1463-1466.
25. Whitington P F. Fetal and infantile hemochromatosis. Hepatology. 2006;43(4):654-660.
26. Whitington P F, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet. 2004;364(9446):1690-1698.
27. Van den Tooren de Groot R, Ottink M, Huiskes E, van Rossum A, van der Voorn B, Slomp J, de Haas M, Porcelijn L. Management and outcome of 35 cases with foetal/ neonatal alloimmune neutropenia. Acta Paediatr. 2014;103(11)e467–e474.
28. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE. Neutro-phil Fc gamma RIIIb defciency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood. 1995;86(6):2403-2413.
29. Koenig JM, Christensen RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med. 1989;321:557-562.
30. La Gamma E F, Alpan O, Kocherlakota P. Effect of granulocyte colony- stimulating factor on preeclampsia-associated neonatal neutropenia. J Pediatr. 1995;126(3):457-459.
31. Sharma G, Nesin M, Feuerstein M, Bussel JB. Maternal and neonatal characteristics associated with neonatal neutropenia in hypertensive pregnancies. Am J Perinatol. 2009;26(9):683-689.
32. Christensen RD, Henry E, Wiedmeier SE, Stoddard RA, Lambert DK. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system. J Perinatol. 2006;26(11):682-687.
33. Jenkins SM, Head BB, Hauth JC. Severe preeclampsia at <25 weeks of gestation: maternal and neonatal outcomes. Am J Obstet Gynecol. 2002;186(4):790-795.
34. Doron MW, Makhlouf RA, Katz VL, Lawson EE, Stiles AD. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr. 1994;125(3):452-458.
35. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Effect of maternal hypertension on neonatal neutropenia and risk of nosocomial infection. Pediatrics. 1992;90(3):430-435.
36. Zook KJ, Mackley AB, Kern J, Paul DA. Hematologic effects of placental pathology on very low birthweight infants born to mothers with preeclampsia. J Perinatol. 2009;29(1):8-12.
37. Mouzinho A, Rosenfeld CR, Sánchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics. 1994;94(1):76-82.
38. Procianoy RS, Silveira RC, Mussi-Pinhata MM, et al; Brazilian Network on Neonatal Research. Sepsis and neutropenia in very low birth weight infants delivered of mothers with preeclampsia. J Pediatr. 2010;157(3):434-438, 438.e1.
39. Koenig JM, Christensen RD. The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol. 1991;165(2):467-473.
40. Wang Y, Gu Y, Philibert L, Lucas MJ. Neutrophil activation inducted by placental factors in normal and pre-eclamptic pregnancies in vitro. Placenta. 2001;22(6):560-565.
41. Faulhaber FR, Silveira RC, Vargas AP, Procianoy RS. Chemokines plasma levels in preterm newborns of preeclamptic mothers. Cytokine. 2011;56(2):515-519.
42. Kuntz TB, Christensen RD, Stegner J, Duf P, Koenig JM. Fas and Fas ligand expression in maternal blod and in umbilical cord blood in preeclapsia. Pediatr Res. 2001;50(6):743-749.
43. Matsubara K, Ochi H, Kitagawa H, Yamanaka K, Kusanagi Y, Ito M. Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia. Hypertens Pregnancy. 1999;18(1):95-106.
44. Güner S, Yiğit S, Cetin M, et al. Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers. Turk J Pediatr. 2007;49(1):55-60.
45. Tsao PN, Teng RJ, Tang JR, Yau KI. Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension. J Pediatr. 1999;135(1):56-59.
46. Zuppa AA, Girlando P, Florio MG, Cota F, Romagnoli C, Tortorolo G. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor efect in neutropenic neonates with suspected sepsis. Eur J Obstet Gynecol Reprod Biol. 2002;102(2):131-136.
47. Enders AC, Carter AM. What can comparative studies of placental structure tell us? A review. Placenta. 2004;25(suppl A):S3-S9.